Option Care Health, Inc.

Option Care Health, Inc.

OPCHNYSE / NASDAQHealthcareSmall cap

$31.59-$0.02 (-0.1%)

Last close · Data as of Nov 20, 2026

Market cap
$3.2B
P/E
15.2x
EV / EBITDA
10.3x
Revenue
$5.6B
Net margin
3.7%
ROCE
13.6%

+12.1% over the last year

Option Care Health, Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
+0.7%
3M
+34.5%
6M
+42.1%
1Y
+12.1%
5Y
+19.0%

52-week range

Day change -$0.02 (-0.1%) from $32 to $32 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in OPCH, bought on each weekday since 2021.

News & filings

What Option Care Health filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

StrengthOperating profit was 6.2 times interest costs.

Concerns

No concern stands out for this company on the data on file.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Option Care Health, Inc. offers home and alternate site infusion services in the United States.

Read moreShow less

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.

Sector
Healthcare
Shares outstanding
156.9M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$3.2B
P/E
15.2x
P/B
2.4x
EV / EBITDA
10.3x
EV / Sales
0.7x
P/S
0.6x
52-week high
$36.59
52-week low
$19.52

Profitability

Operating margin
6.0%
Net margin
3.7%
EBITDA margin
7.2%
ROE
15.6%
ROCE
13.6%
ROIC
10.5%
ROA
6.0%
Asset turnover
1.63

Growth

Revenue
$5.6B
Revenue growth, 1Y
13.0%
Revenue CAGR, 3Y
12.7%
Net profit growth, 1Y
-2.0%
Free cash flow
$217.1M

Solvency

Current ratio
1.53
Debt / Equity
0.96
Debt / Assets
0.37
CFO / Net profit
1.25
Cash / Market cap
7.4%

Where the revenue went

Of every $100 of FY2025 revenue, $4 was left as net income.

Option Care Health, Inc. income statement flow, FY2025
Option Care Health, Inc. income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$4.6B
RevenueGross profit$1.1B
Gross profitSelling, general and administrative$682.5M
Gross profitOther operating expenses$67.5M
Gross profitOperating income$337.9M
Operating incomePretax income$282.9M
Operating incomeInterest and other expense$55.0M
Pretax incomeTax and other$75.3M
Pretax incomeNet income$207.6M

Revenue and net profit

Revenue grew 13.0% in FY2025; net profit is the dashed line.

Option Care Health, Inc. revenue and net profit by fiscal year
Option Care Health, Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$3.9B$150.6M
FY2023$4.3B$267.1M
FY2024$5.0B$211.8M
FY2025$5.6B$207.6M

Cash flows

FY2025: $258.4M from operations, $217.1M free after investment (dashed).

Option Care Health, Inc. operating and free cash flow by fiscal year
Option Care Health, Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$267.5M$232.2M
FY2023$371.3M$329.4M
FY2024$323.4M$287.8M
FY2025$258.4M$217.1M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$5.6B+13.0%1Y
EBITDA
$408.1M+3.0%1Y
Net profit
$207.6M-2.0%1Y
Cash from operations
$258.4M-20.1%1Y
Free cash flow
$217.1M-24.5%1Y
Revenue CAGR, 3Y
12.7%
Net profit CAGR, 3Y
11.3%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$5.6B$408.1M$207.6M$217.1M15.7%+13.0%-2.0%

Monthly returns

Month-by-month returns of OPCH across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$3.5B
Liabilities$2.1B
Equity$1.3B
Paid-in capital$1.3B
Retained earnings$876.9M
Treasury stock$818.2M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; OPCH highlighted.

P/E against peers

OPCH trades at 15.2x earnings against a peer median of -6.8x.

  1. Option Care Health, Inc. (this company)15.2x

EV / Sales, for the companies without earnings

Not shown (no positive earnings and no EV / Sales): Denali Therapeutics Inc., Dyne Therapeutics, Inc.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Option Care Health, Inc.OPCHthis company$3.2B15.2x2.4x15.6%10.3x
Beam Therapeutics Inc.BEAM$3.4B-42.2x2.7x-6.5%-9.0x
Tango Therapeutics, Inc.TNGX$3.2B-31.5x9.3x-29.3%-28.7x
Denali Therapeutics Inc.DNLI$3.2B-6.2x3.2x-50.6%-5.6x
Haemonetics CorporationHAE$3.2B32.6x4.0x12.2%15.5x
Relay Therapeutics, Inc.RLAY$3.2B-11.5x5.6x-48.8%-10.4x
Alignment Healthcare, Inc.ALHC$3.1B—17.4x-0.4%62.7x
Dyne Therapeutics, Inc.DYN$3.0B-6.8x3.1x-45.9%-5.3x
Warby Parker Inc.WRBY$3.0B1803.7x8.0x0.4%64.7x
Peer median—-6.8x4.8x-17.9%-5.4x

Year-to-date ROI

OPCH since 1 January, against earlier years.

Historical volatility

OPCH's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

Option Care Health, Inc. operating margin by fiscal year
Option Care Health, Inc. operating margin by fiscal year
DateOperating margin
FY20226.1%
FY20237.3%
FY20246.4%
FY20256.0%
LineFY2025
Cost of revenueCost Of Revenue$4.6B
Gross profitGross Profit$1.1B
Operating expensesOperating Expense$750.0M
Selling, general and administrativeSelling General And Administration$682.5M
Depreciation and amortisationDepreciation And Amortization In Income Statement$67.5M
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement$67.5M
Total expensesTotal Expenses$5.3B
Pretax incomePretax Income$282.9M

Learn while you research

Academy chapters picked for Option Care Health, Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
  3. 03 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  4. 04 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  5. 05 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →